LCLAT1 and Parkinson disease: Ablation of ALCAT1 gene or inhibition of ALCAT1 activity by pharmacological agents, prevented MPTP-induced neurotoxicity, mitochondrial dysfunction, apoptosis, and locomotive defects, typical of PD.